Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias W Beckmann

Showing results (511-520 of 799) with videos related to

Pageof 80
Sort By:
Reproductive Biomedicine Online|December 5, 2017
Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissueMatthias W Beckmann, Ralf Dittrich, Laura Lotz, et al.
Precision Clinical Medicine|January 22, 2025
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impactHanna Huebner, Pauline Wimberger, Elena Laakmann, et al.
Breast Cancer Research and Treatment|July 6, 2012
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancerMartin Schuler, Ahmad Awada, Philipp Harter, et al.
HLA|August 5, 2024
Validation and functional follow-up of cervical cancer risk variants at the HLA locusRieke Eisenblätter, Finja Seifert, Peter Schürmann, et al.
Breast Cancer Research and Treatment|November 1, 2016
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN studyNadia Harbeck, Steffen Saupe, Elke Jäger, et al.
Breast Cancer Research : BCR|September 20, 2015
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trialPeter Widschwendter, Thomas Wp Friedl, Lukas Schwentner, et al.
Journal of the National Cancer Institute|October 13, 2018
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and PrognosisElisabeth Trapp, Wolfgang Janni, Christian Schindlbeck, et al.
Breast Cancer Research : BCR|April 12, 2012
Characterizing mammographic images by using generic texture featuresLothar Häberle, Florian Wagner, Peter A Fasching, et al.
Journal of Medical Genetics|February 1, 2011
High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasiaSerena Nik-Zainal, Reiner Strick, Mekayla Storer, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
Pageof 80

Showing results (511-520 of 799) with videos related to

Sort By:
Pageof 80
Reproductive Biomedicine Online|December 5, 2017
Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissueMatthias W Beckmann, Ralf Dittrich, Laura Lotz, et al.
Precision Clinical Medicine|January 22, 2025
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impactHanna Huebner, Pauline Wimberger, Elena Laakmann, et al.
Breast Cancer Research and Treatment|July 6, 2012
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancerMartin Schuler, Ahmad Awada, Philipp Harter, et al.
HLA|August 5, 2024
Validation and functional follow-up of cervical cancer risk variants at the HLA locusRieke Eisenblätter, Finja Seifert, Peter Schürmann, et al.
Breast Cancer Research and Treatment|November 1, 2016
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN studyNadia Harbeck, Steffen Saupe, Elke Jäger, et al.
Breast Cancer Research : BCR|September 20, 2015
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trialPeter Widschwendter, Thomas Wp Friedl, Lukas Schwentner, et al.
Journal of the National Cancer Institute|October 13, 2018
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and PrognosisElisabeth Trapp, Wolfgang Janni, Christian Schindlbeck, et al.
Breast Cancer Research : BCR|April 12, 2012
Characterizing mammographic images by using generic texture featuresLothar Häberle, Florian Wagner, Peter A Fasching, et al.
Journal of Medical Genetics|February 1, 2011
High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasiaSerena Nik-Zainal, Reiner Strick, Mekayla Storer, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
Pageof 80